Alternatives to Calcium Acetate If You Can't Fill Your Prescription

Calcium acetate is a widely prescribed phosphate binder for dialysis patients with end-stage renal disease (ESRD). When it is out of stock or unavailable at your local pharmacy, it can feel alarming — especially because dialysis patients cannot safely skip doses. The good news is that several alternative phosphate binders are FDA-approved and can be discussed with your nephrologist if you need a temporary or permanent switch.

Important: Never switch phosphate binders on your own. Your nephrologist needs to guide any change to ensure your blood phosphate and calcium levels stay in a safe range.

Why Phosphate Binders Are Not Interchangeable Without Medical Guidance

Different phosphate binders work by different mechanisms and have different effects on calcium, iron, and other blood levels. Calcium-based binders like calcium acetate add calcium to the body, which can be a concern in patients who already have high calcium levels (hypercalcemia). Non-calcium alternatives like sevelamer are preferred for patients with hypercalcemia or a history of vascular calcification. Your nephrologist will look at your current lab values before recommending a switch.

Alternative 1: Sevelamer Carbonate (Renvela)

Sevelamer carbonate (brand name Renvela) is one of the most commonly prescribed alternatives to calcium acetate. It is a non-calcium phosphate binder, which means it does not raise blood calcium levels. This makes it a preferred option for patients who already have hypercalcemia or are at risk for vascular calcification.

Sevelamer carbonate is available as a tablet (400 mg or 800 mg) or as a powder packet. Some studies suggest it may reduce cardiovascular mortality in dialysis patients. The main drawbacks are a higher pill burden (patients may need 6–12 tablets per day) and more gastrointestinal side effects like nausea and dyspepsia. A generic version is available and is considerably less expensive than the brand-name Renvela.

Alternative 2: Sevelamer Hydrochloride (Renagel)

Sevelamer hydrochloride (brand name Renagel) is closely related to sevelamer carbonate. It is also a non-calcium phosphate binder and works in essentially the same way. One distinction is that the hydrochloride formulation can occasionally reduce serum bicarbonate levels, potentially contributing to metabolic acidosis — a concern that the carbonate formulation (Renvela) does not carry. Your nephrologist will choose between these based on your individual lab values.

Alternative 3: Lanthanum Carbonate (Fosrenol)

Lanthanum carbonate (brand name Fosrenol) was FDA-approved in 2004 as a chewable tablet. It is a non-calcium phosphate binder that requires fewer tablets per meal than sevelamer — a meaningful advantage for patients who struggle with a high pill burden. Lanthanum is minimally absorbed by the body and is primarily eliminated through the liver.

The main drawbacks of lanthanum carbonate are its high cost (generic versions have become more available in recent years, which helps) and GI side effects including nausea and diarrhea. Long-term safety data has generally been reassuring, but your nephrologist will weigh this against other options based on your specific situation.

38,179+ patients found their medications in stock

38K+

Find Calcium Acetate In Stock Today →

Alternative 4: Ferric Citrate (Auryxia)

Ferric citrate (brand name Auryxia) is an iron-based phosphate binder that serves a dual purpose — it lowers phosphate levels and also helps correct iron deficiency, which is very common in dialysis patients. This makes it a particularly attractive option for patients who need both phosphate management and iron supplementation.

The main limitations of ferric citrate are its higher cost and GI side effects including nausea, constipation, and darkening of the stool (from the iron). It requires more tablets per day than calcium acetate. Its long-term safety profile is still being studied.

Alternative 5: Sucroferric Oxyhydroxide (Velphoro)

Sucroferric oxyhydroxide (brand name Velphoro) is a chewable iron-based phosphate binder. One of its main advantages is a lower required pill count — one chewable tablet three times daily with meals for most patients. It is calcium-free and iron-based. Side effects include discolored (dark) stools, nausea, and diarrhea. It is generally more expensive than calcium acetate or sevelamer generics.

Skip the calls, skip the stress.

Find Calcium Acetate In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Alternative 6: Calcium Carbonate (OTC)

Calcium carbonate (the main ingredient in antacids like Tums) is sometimes used as a cost-effective phosphate binder. However, it is less efficient than calcium acetate — equimolar doses of calcium acetate bind twice as much phosphorus as calcium carbonate. It also adds more calcium to the body per dose, which increases hypercalcemia risk. It should only be used as a phosphate binder under medical supervision and is not FDA-approved specifically for this indication.

How to Talk to Your Nephrologist About Switching

If you cannot find calcium acetate, call your nephrologist's office as soon as possible. Tell them:

That your pharmacy does not have calcium acetate in stock

Which form and dosage you are currently taking

How many doses you have left (so they know how urgent the situation is)

Whether you have any history of hypercalcemia (which affects which alternative they might choose)

First, Try Harder to Find Calcium Acetate

Before switching medications, exhaust your options for finding calcium acetate. See our guide on how to find calcium acetate in stock near you or check the latest calcium acetate availability update. Switching phosphate binders requires recalibrating your dose and monitoring your labs closely — so staying on calcium acetate if you can find it is often the easiest path.